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INTRODUCTION 
Over years the effective treatment for GERD has been antireflux 
medication and surgery. Patients who were not improving on medical 
therapy or are not conducive are nowadays surgically treated. This 
technique was originally pioneered by Rudolf Nissen. In a young male 
patient with penetrating oesophageal ulcer he did the first fundoplication 
to protect the oesophagogastric anastamosis . As he followed up the 
patient he noticed that the patient's reflux symptoms were no more 
present. Nissen again reattempted his fundoplication on a male patient 
with a paraesophageal hernia which had incarcerated. It produced 
excellent clinical results. Eventually he published the first description of 
his surgical procedure in 1956, which turned out to be the birthchild of 
the current era of antireflux surgery. 
In original Nissen’s fundoplication, he united the posterior wall of 
the stomach with the anterior wall completely around the fundus of the 
stomach to provide a full 360-degree wrap of 4-5cm around the lower 
esophagus. One or two stitches should include the wall of the esophagus 
to prevent slippage of the cardia. In Nissen-Rossetti’s modification of the 
original fundoplication, he used only the anterior wall of the fundus and 
constructed a 360-degree wrap enclosing the distal oesophagus. In the 
initial Nissen-Rossetti modification he did not divide the short gastric 
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vessels. However, when a tension-free wrap could not be obtained, the 
short gastric vessels were sacrificed. The role of Operative treatment for 
Gastro Oesophageal Reflux Diseases and Hiatus Hernias have changed 
dramatically during the 90’s. The driving force behind increased surgical 
numbers is the development of minimal invasive surgery. 
3,4,5
  
Although the techniques of Antireflux surgery has not changed, the 
approach has become more acceptable to the patient and referring 
physician because of small incisions, relatively short hospital stay and 
lack of post operative pain when compared to open approach. 
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AIM OF THE STUDY 
To assess whether Laparoscopic Nissen’s floppy fundoplication 
really improves the quality of life compared to medical management and 
to assess the usefulness of surgery based on risk vs benefit ratio To 
evaluate the patients undergoing Laparoscopic Nissens fundoplication by 
comparison of their preoperative and postoperative Quality of life, 
dependency on medication and endoscopic findings. 
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REVIEW OF LITERATURE 
HISTORY : 
It was not until early 1900 till radiological studies gained 
importance that hiatus hernia was recognized to be a pathologic entity. In 
mid 1930’s post world war 1 it was identified as the precipitating cause 
for Oesophagitis. Initially the symptoms of Gastro oesophageal reflux 
was associated with hiatus hernia. This led to conclusion of hernia being 
the primary cause and attempts were made to correct hernia with simple 
closure of crura. However since lower oesophageal sphincter was not 
repaired, this procedure was a uniform failure and never gained universal 
acceptance. 
In 1951, Philip Allison and Norman Barrett established the 
relationship between hiatal hernia, gastrooesophageal reflux and erosive 
oesophagitis. Allison explained that the crural sling and clasp 
musculature is the anatomic correlate to the Lower Oesophageal 
Sphincter and described it to be the primary mechanism which helps in 
preventing pathologic reflux. He performed a procedure where he 
restored the antireflux mechanism by reducing the cardia of stomach 
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which was herniating, by suturing to the diaphragmatic abdominal surface 
and lastly by loose closure of the hiatus.  
However, this technique did not produce the desired results and his 
long-term recurrence rate of hiatus hernia at end of 20 years was almost 
49%. Still, his repair represented the first effort in the right direction and 
he was the first to emphasize the importance of placing Gastro 
oesophageal junction in the intra abdominal position. He was thus 
credited to have initiated the modern era of antireflux surgery. 
Subsequent efforts were made to develop procedures which 
anchored the lower oesophagus in the intra abdominal position. Initially, 
the surgeries employed were various forms of Gastropexy, where the 
stomach was pulled down in the abdomen and attached to the anterior 
abdominal wall or any posterior peritoneal structure strong enough to 
maintain it. This however placed the stomach and oesophagus under a 
great deal of continual tension which further stressed respiration and 
swallowing.  
This was followed by Hill’s procedure where gastro oesophageal 
junction was anchored posteriorly to the median arcuate ligament. Since 
this also did not produce the desired results, Belsey Mark 4 and Nissens 
fundoplication came into vogue.  Belsey mark 4 is in essence a partial 
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270-280° fundoplication whereas Nissens is complete 360° 
fundoplication.   
In 1939, Rudolf Nissen did a fundoplication on a male patient with 
penetrating oesophageal ulcer to safeguard his oesophagogastric 
anastomosis. During regular post operative revisits, he noted complete 
disappearance of his reflux symptoms. After few years, fed up with the 
then conventional hiatus hernia surgeries, Nissen again did his 
fundoplication on a male patient, this time with paraoesophageal hernia 
which had gone for incarceration. He had excellent outcomes. Nissen first 
published the description of his surgery in 1956, thereby pioneering the 
modern era of antireflux surgery. However Nissens fundoplication also 
had severe post operative complications, most of which could be 
attributed to faulty techniques and inaccurate patient selection. It was not 
a simple matter of wrapping the stomach around the lower oesophagus. 
Judgement and experience is vital in determining how long and how tight 
to make the fundoplication, what portion of the stomach should be used 
and what all conditions preclude the use of this surgery. If the 
fundoplication is too long or tight, it can result in dysphagia / 
odynophagia. Surgeons started introducing varieties of partial 
fundoplication to get around this problem. These included Dor (Anterior 
180), Toupet (Posterior 270) and Belsey (270 Anterior Transthoracic). 
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The problems lie in suturing the fundus of stomach to the oesophagus. 
Besides subjecting the suture line to a great deal of stress, it also has 
limited durability. This high degree of disruption never allowed these 
procedures to take off.  
The most durable of these partial fundoplication techniques was the 
Belsey Mark 4 operation. In this procedure which is performed 
transthoracic the oesophagus is adequately mobilized to avoid tension. In 
situations where the oesophagus has shortened, aggressive mobilization 
does not produce a tension free repair. To counter this, oesophageal 
lengthening technique was done by making a tube about the diameter of 
the oesophagus and 5cm in length in the lesser curvature of the stomach 
and constructing a Belsey fundoplication around the tube. This was called 
the Collin Belsey repair named after Dr. Leigh Collin and Dr. Ronald 
Belsey. The major drawback of this procedure is acid production within 
the tubularised portion of the stomach. Also this procedure is difficult to 
teach and has very less margin for error. In an experienced surgeon Mark 
Belsey operation has similar success to Nissens fundoplication.   
The role for surgery as a treatment for Gastro Oesophageal Reflux 
Disease and Hiatal Hernias changed dramatically during the 90’s post the 
laparoscopic era.   
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Once a not so common procedure, nowadays many antireflux 
surgeries and hiatal hernia repairs are being performed in increased 
number of hospitals around the world, the driving force behind increased 
surgical numbers being the advancement of minimal invasive surgery.  
Although the basic technique of Nissens original fundoplication 
has not changed, the approach has become far more acceptable to both 
the patient and referring doctor because of smaller incisions, relatively 
shorter duration of hospital stay and minimal post operative pain when 
compared to the open technique. 
PATHOPHYSIOLOGY 
The oesophagus, lower oesophageal sphincter and stomach may be 
viewed similar to a plumbing circuit, as put forward by Stein and co. He 
compared functioning of the oesophagus with an antegrade pump, the 
Lower Oesophageal Sphincter to a valve and stomach to that of a 
reservoir. The abnormalities which cause GERD may arise from any of 
the above three.  
Poor motility of the oesophagus causes reduced clearing of the 
acid. Dysfunction of LES leads to reflux of huge quantities of stomach 
acid secretion. Delay in emptying of the stomach leads to increasing 
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volume and pressure within the stomach, ultimately defeating the valve 
mechanism causing GERD.  
Both medically and surgically it is important in identifying the 
defective components to give proper efficacious treatment. 
Oesophageal defense mechanisms : 
Oesophageal defense mechanisms are broadly classified into 2 categories  
1.  Oesophageal clearance mechanism and 
2.  Mucosal resistance  
Proper oesophageal clearance becomes extremely important in 
preventing injury to the mucosa. Oesophageal clearance should be 
adequate enough to neutralize acid reflux through the lower oesophageal 
sphincter.  
Mechanical clearance is achieved through oesophageal peristalsis, 
whereas chemical clearance is achieved with saliva. In normal clearance, 
the time of exposure of the esophagus to refluxed acid or bile and gastric 
acid mixture is limited, whereas in case of abnormality in peristalsis there 
is inefficiency and delay in clearing the acid. 
It is still not clear whether either the primary defect or increased 
oesophageal acid exposure is the cause of peristaltic dysfunction.  
18 
 
 
 
Dysfunction of  LES 
The lower oesophageal sphincter (LES) is a high pressure zone 
with raised intraluminal pressures at gastro oesophageal junction as 
defined by manometry. It is not distinct as an anatomical structure but as 
a unique physiological entity located just cephalad to the Gastro 
oesophageal junction. 
Several factors contribute to this high pressure zone :  
1.  Intrinsic musculature of the distal oesophagus. They remain in a 
state of tonic contraction. They relax during swallowing and return to 
the contraction state post swallowing.   
2.  Sling fibres of Cardia These fibres are at the same anatomical depth 
as the circular fibres of the oesophagus. However their orientation is 
in a different direction. They run from the fundus of Cardia to the 
lesser curvature diagonally. These fibres are responsible for the lower 
oesophageal high pressure zone.   
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3.  Diaphragm - During inspiration the antero posterior diameter of the 
crural opening is decreased causing an increase in pressure in the 
lower oesophagus. Usually LES pressure is assessed at mid or end 
expiration   
4.  Transmitted pressure of abdominal cavity – Intra abdominal 
pressure is usually higher than intra thoracic pressure which is 
negative. A Gastro Oesophageal Junction firmly anchored within the 
abdominal cavity will be exposed to greater transmural pressure than 
one which herniates into the posterior mediastinum 
For proper functioning of Lower Oesophageal Sphincter, this junction 
must be located intra abdominally so as to facilitate the crura of the 
diaphragm to help the extrinsic sphincteric function of LES. Besides, the 
LES should be of normal length with normal sphincter pressure and 
should have normal regular number of transient relaxation episodes 
(relaxing of LES when there is no swallowing). 
Lower Oesophageal Sphincter dysfunction is caused by any of the 
above mechanisms:  
Most common being in the below order,  
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- Transient relaxed LES  
- Permanently relaxed LES (and)  
- Transient increase of intra-abdominal pressure to overcome lower 
oesophageal sphincter pressure. 
Gastro Oesophageal Reflux occurs when the high pressure zone in 
lower oesophagus is inadequate to prevent reflux of gastric contents or 
when a sphincter with normal pressure spontaneously relaxes and is 
dissociated with the peristaltic wave of the body of oesophagus. 
Even small changes in high pressure zone can compromise the 
effectiveness of LES. Thus reflux occurs in normal people too.  
Delayed gastric emptying 
The postulated theory of delayed stomach emptying leading to 
Gastrooesophageal reflux is due to increasing reflux of gastric contents 
leading to increase in pressure within the stomach leading to increase in 
the pressure pressing on the LES. LES pressure is ultimately 
overwhelmed leading to gastric reflux.   
Hiatus hernia 
Hiatal hernia is frequent in patients suffering from reflux disease. 
However there can exist patients with Hiatus hernia not having any reflux 
symptoms. 
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Types of Hiatal Hernias 
Type 1 – Sliding hiatal hernia – (90%) When Gasto Oesophageal 
Junction is not maintained intraabdominally by phrenooesophageal 
ligament and herniates into mediastinum. (phrenooesophageal membrane 
continues with endoabdominal fascia which reflects onto the oesophagus 
at hiatus just superficial to the peritoneal reflection at hiatus continuing 
into the mediastinum) 
Type 2 Rolling hernias (Paraoesophageal hernia) – when GEJ is 
anchored in abdomen but hiatal defect is large enough to allow herniation 
of viscera into the mediastinum. Also playing a role is the negative 
intrathoracic pressure which also aids this migration.  
Type 3 Mixed hernias (combination of both the above) 
Type 4 – when there is herniation of Colon and Spleen  
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Obesity as a contributing factor 
Studies have revealed GERD to be more common in patients with 
morbid obesity and those with high Body Mass Index. There is a 
hypothesis that states, the more obese the patient, the increased exposure 
to oesophageal acid. Aiding this hypothesis is a documentation of dose-
response association where an increase in BMI increases the incidence of 
gastrooesophageal reflux with its complications. Hence, the 
pathophysiology of GERD in morbidly obese patients is different from 
that of normal patients. The implication of this is that the correction of 
reflux in morbidly obese patients is better achieved with a procedure that 
first controls obesity. 
GRADES OF GERD : 
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Los Angeles Classification  
Grade 
A 
Single mucosal breaks < 5 mm in maximal length 
Grade 
B 
One or more mucosal breaks > 5mm, but without continuity 
across mucosal folds 
Grade 
C 
Mucosal breaks continuous between > 2 mucosal folds, but 
involving less than 75% of the oesophageal circumference 
Grade 
D 
Mucosal breaks involving more than 75% of oesophageal 
circumference 
 
 
B) The Savary – Miller grading system 
Grade 1: Single or multiple erosions on a single fold. Erosions may be 
exudative or erythematous. 
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Grade 2: Multiple erosions affecting multiple folds. Erosions may be 
confluent. 
Grade 3: Multiple circumferential erosions. 
Grade 4: Ulcer, stenosis or oesophageal shortening. 
Grade 5: Barrett's epithelium. Columnar metaplasia in the form of 
circular or non-circular (islands or tongues) extensions. 
 
COMPLICATIONS OF GERD : 
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Complications of GERD are due to injury to injury to oesophageal 
mucosa, Laryngeal or respiratory epithelial lining due to gastric acid 
They are divided into : 
1. Mucosal complications – Oesophagitis, stricture 
2. Extraoesophageal or respiratory complications – Laryngitis, 
recurrent pneumonia and progressive pulmonary fibrosis 
3. Metaplastic and neoplastic complications – Barrett’s oesophagus, 
Oesophageal adenocarcinoma 
Mucosal complications :  
The potential injurious components refluxing into oesophagus are 
due to gastric secretions like Hcl, pepsin, secretions from pancreas and 
biliary tract regurgitating from duodenum to stomach. Acid secretion by 
itself only minimally injures the gastric mucosa, but on combining with 
acid and pepsin it becomes very dangerous. H+ ions damage oesophageal 
mucosa only below pH of 2.  
Similarly duodenal juice alone is not dangerous but combination of 
duodenal juice with gastric acid is highly deleterious.  
Oesophageal stricture : 
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Diseases producing oesophageal stricture is classified into 3 groups 
(1)  Intrinsic diseases – include those which cause narrowing of 
oesophageal lumen by fibrosis, inflammatory or neoplastic changes. 
(2)  Extrinsic disease compressing upon oesophagus causing luminal 
narrowing by direct invasion or enlarged lymphadenopathy  
(3)  Diseases disrupting oesophageal peristalsis and normal functioning 
of LES by effect on oesophageal smooth muscle and its nerve 
supply. 
Other causes for oesophageal stricture include  
Acid peptic disease  
Autoimmune disease   
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Infectious diseases 
Iatrogenic cause 
Caustic materials  
Medication / radiation-induced  
Malignancy 
 
Oesophageal strictures are sequelae of Reflux resulting in 
oesophagitis. They take origin from the squamocolumnar junction 
averaging a length of 1-4 cms. 
Two main causes of peptic oesophageal stricture are : 
o LES Dysfunction:  The LES mean pressure among patients having 
stricture is lower than those of healthy individuals.  A study by 
Ahtaridis et al revealed a mean sphincter pressure of 4.9 mm Hg in 
patients having peptic oesophageal stricture in comparison with 20 
mm Hg in normal control patients.
 
 Any Lower Oesophageal Sphincter 
pressure measuring lesser than 8 mm Hg shows significant correlation 
with presence of peptic oesophageal stricture. 
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o Motility disorders: They result in poor oesophageal clearance. It is 
found that 63% of patients having stricture suffered from other 
motility problems in comparison to 32% in case of normal subjects. 
 Patients suffering from strictures complain of heartburn, dysphagia, 
odynophagia, impaction of food, loss of weight and chest pain. 
 Progressive dysphagia from liquids to solids 
 Atypical presentation including chronic cough, asthma, asthma due to 
aspiration of acid or food particles. 
 
Investigations: 
 Barium oesophagram : 100% sensitive in cases where diameter of 
lumen is smaller than 9 mm. It is 90% sensitive when diameter is larger 
than 10 mm. 
 Chest X ray PA and lateral : Chest X Ray can be used as an 
adjunctive investigation when oesophageal stricture is suspected due to 
any extrinsic compression. 
 CT scan : Has 60-68% accuracy in its ability to estimate the depth of 
invasion of tumour. It has 82% accuracy to help determine other 
organ invasion. 
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 Endoscopic ultrasound (EUS) : It has maximum accuracy in  
helping to identify the local invasion of tumour with its extent in case 
of any malignancy. 
It is 92% accurate in helping to estimate the depth of tumor invasion 
Twenty-four hour oesophageal pH monitoring 
Oesophageal manometry 
Oesophagogastroduodenoscopy (EGD) 
Treatment : 
Medical – PPI’s remain mainstay of management 
Surgical - Wire-guided polyvinyl bougies - Savary-Gilliard, American 
dilators,  
Fluoroscopic balloon dilators (FBD)  
Intralesional injection of steroid 
Expandable polyester silicone-covered stent 
Oesophagus-sparing surgeries - Antireflux surgeries(Nissen’s or Belsey 
partial fundoplication), Oesophageal lengthening by antireflux operations 
(Collin-Nissen or Belsey gastroplasty) 
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Oesophageal resection with reconstruction using gastric or colonic 
interpositioning or with jejunal segment 
Respiratory complications : 
Two mechanisms have been proposed.  
1. Reflux theory : Respiratory symptoms are due to aspiration of gastric 
contents.  
There are 5 points supporting reflux mechanism: 1.Evidences suggest 
a strong association between hiatus hernia and idiopathic pulmonary 
fibrosis 2.Pathological acid exposure in proximal oesophagus is often 
identified in these patients with respiratory symptoms and reflux 
3.Scintigraphy studies show ingested Radio-isotope to be aspirated in 
patients having respiratory symptoms with reflux 4.Tracheal and 
oesophageal pH monitoring in patients with reflux show acidification of 
trachea associated with oesophageal acidification 5.Animal experiments 
reveal that HCL when ingested in trachea profoundly increases airway 
resistance  
2. Reflex theory:  
Vagal mediated bronchoconstriction follows acidification in lower 
oesophagus. In support of this theory bronchoconstriction occurs after 
infusing acid into lower oesophagus. This is due to common embryonal 
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origin of tracheooesophageal tract and its shared nerve supply from 
vagus. Treatment is by Proton pump inhibitor or Antireflux surgery 
Metaplasia and Neoplasia : 
Barret’s oesophagus : 
 
 
 
 
         
It presents as an entity where the tubular oesophageal lining of 
squamous epithelium is replaced by columnar epithelium. Norman 
Barrett first described it in 1950. It is an acquired abnormality with an 
incidence of 7-10% in patients suffering from GERD and it signifies 
the end stage of the natural history of the disease. It is identified when 
the columnar mucosa extends atleast 3cm into the oesophagus or 
during endoscopy by intestinal metaplasia of any length being visible. 
The hallmark of intestinal metaplasia is the presence of Goblet cells.  
Pathophysiology : Metaplasia at Gastro oesophageal junction 
begins with distal oesophageal squamous mucosa converting to 
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cardiac type epithelium. This is because of the exposure to stomach 
acids and contents into the oesophagus resulting from prolapse of 
oesophageal squamous mucosa. This causes inflammation in the 
Gastro oesophageal junction and metaplasia both of which results in 
muscle function loss and defective LES, permiting free reflux with 
increased risk of of mucosal injury. Intestinal metaplasia within the 
LES may result in Barrett’s metaplasia of the body of oesophagus.  
Treatment :  
Based on classification of Barrett’s oesophagus 
1. No dysplasia  
2. Indefinite for dysplasia – Aggressive antireflux therapy (60mg/day 
PPI), Repeat biopsy in 3 months  
3. Low grade dysplasia – Aggressive antireflux therapy. Sugical - 
Nissens fundoplication in medical refractory cases 
4. High grade dysplasia – Confirmation by 2 experienced pathologists. 
Oesophagectomy (?extent) 
An important consideration in Barrett’s oesophagus is, these patients 
present with severe Gastro oesophageal reflux, and its sequelae, like large 
Hiatus hernia, short oesophagus, stricture and poor motility. These factors 
make successful antireflux surgery a challenge. Data also suggests that 
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fundoplication in Barrett’s oesophagus do not have the same level of 
success as those performed in patients without Barrett’s oesophagus   
Barrett’s Oesophagus and adenocarcinoma : 
 
Barrett's esophagus is a premalignant condition. Its malignant 
sequela, oesophagogastric junctional adenocarcinoma, has a mortality 
rate of over 85%.  The relative risk of esophageal adenocarcinoma is 
approximately 10 in those with Barret's esophagus, compared to the 
general population. Most patients with oesophageal carcinoma survive 
less than 1 year. In addition, Barrett’s oesophagus has been reported in 
patients with no reflux symptoms. The risk of oesophageal 
adenocarcinoma is increased 30 to 40 times among patients with Barrett’s 
compared with those without this condition. EAC continues to increase at 
a rate greater than any other cancer in the Western world (>500% since 
the 1970s), exceeding that of other more common cancers such as breast, 
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colon, lung, and prostate cancer. In 2009, it is estimated that 16,470 new 
cases of oesophageal cancer will be diagnosed in the United States, of 
which close to 60% will be adenocarcinomas.  Despite all the recent 
advances in the diagnosis and management of this lethal cancer, the 
overall 5-year survival rate remains dismal 
 
 
This specimen in above picture shows a carcinomatous lesion at the 
junction between the oesophagus and stomach. It is a large irregular 
mass. The main aim of endoscopy in Barrett's oesophagus lies in 
detecting these lesions early on when rate of cure is high 
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Approximately 30% of oesophageal cancers, who have undergone 
pre op chemo and radiotherapy present with no residual cancerous lesion 
in the resected specimen. These patients survive longer than surgery- 
alone patients. The treatment trials should be tailored to each patient to 
provide maximum benefit. 
Treatment of choice for early oesophageal cancer proven on biopsy 
is surgical removal of intrathoracic oesophagus.  Oesophageal 
adenocarcinomas can metastasize to chest lymph nodes. It is best to 
confirm the diagnosis before surgical resection. 
In early detection of adenocarcinoma, in the presymptomatic stage in 
patients with Barrett's oesophagus, chances of a surgical cure is high - 50 
to 80%. 
The treatment of choice for patients with invasive oesophageal 
cancer is pre-op chemo RT followed by surgery. Each patient is staged 
using diagnostic modalities like CT scan, MRI, endoscopic ultrasound, 
and laparoscopic examination prior to chemo RT. 
 
ANATOMY 
The oesophagus can further be sub-divided into 1. Cervical 
oesophagus  2. Thoracic oesophagus and  3. Abdominal oesophagus. It 
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consists of an inner circular muscle layer and outer longitudinal muscle 
layer. There is a smooth transition of the upper proximal 1/3
rd
 which 
comprises of striated muscle, to smooth muscle in the distal 2/3
rd
. The 
upper oesophagus comprises of upper oesophageal sphincter (UES), 
which has 2 muscles, Cricopharyngeus and Thyropharyngeus. 
The distal lower thoracic oesophagus lies to the left of the midline. 
It continues to become the abdominal oesophagus in the region where 
thoracic oesophagus enters abdomen through the oesophageal hiatus. The 
oesophageal hiatus is formed from the Right crus of the diaphragm 
forming an oesophageal sling surrounding it with left and right pillars. 
The contraction of diaphragm causes narrowing of the oesophagus.  
Relationship between phrenooesophageal ligament with oesophagus and 
diaphragm. 
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At this level, phrenooesophageal ligament encircles the 
oesophagus. The lower limit of this ligament is marked by a prominent 
pad of fat lying on the anterior oesophageal surface which demarcates the 
oesophagogastric junction. The junction is intraabdominal forming the 
His angle. This acute angle combined with normal abdominal oesophagus 
length causes normal closure of the oesophagus in case of high intra-
gastric and intra-abdominal pressures. 
The lower oesophageal sphincter or in other terms the distal 
oesophageal high-pressure zone (HPZ) comprises of the most distal 
segment of oesophagus measuring 2-5 cm length. Maintanence of 
adequate intra-abdominal HPZ is very important to prevent Gastro 
oesophageal reflux. This is formed by a complex architecture of smooth 
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muscle fibers, which are classically identified by oesophageal 
manometry. Gastro Oesophageal Reflux is due to malfunctioning or 
abnormalities of either one or more of these anatomic features. Hence a 
complete evaluation and correction pre operatively  and intra operatively 
of all these defective anatomical features is necessary. 
Blood supply of Oesophagus and Stomach 
Oesophagus has segmental blood supply. Cervical oesophagus is 
supplied by inferior thyroid artery. Branches from bronchial arteries and 
directly off Aorta play a role in supplying the proximal oesophagus and 
distal thoracic oesophagus respectively. Left gastric artery branches and 
Inferior phrenic artery branches give supply to the abdominal 
oesophagus. A more consistent branch, Belsey artery plays a role in 
connecting the left gastric artery with inferior phrenic arteries. 
39 
 
 
Arterial blood supply and lymphatic drainage of the Oesophagus. 
Stomach has a rich blood supply with overlapping vessels. The 
lesser curvature is supplied by left gastric artery from Coeliac trunk and 
Right gastric artery from Hepatic artery proper. The greater curvature 
derives supply from Right gastro epiploic originating from the 
gastroduodenal artery and Left gastroepiploic and Short gastric arteries 
originating from Splenic artery. Excellent collaterals around the stomach 
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allow ligation of many of the arteries around the stomach without any 
significant risk of ischemia.  
Aberrant Left Hepatic Artery: 
An aberrant left hepatic artery is a branching of the left gastric 
artery which provides arterial supply to Left lobe of liver. It passes 
through the gastrohepatic ligament to supply the left lobe. The incidence 
of this aberrant Left Hepatic artery ranges from 3% to 25%. Is is 
especially significant in surgeries for liver transplant and surgeries 
performed near the gastrohepatic ligament like oesophagogastrectomy, 
gastrectomy, gastric bypass, and antireflux procedures. 
Although recent reports say that there is only transient liver 
enzyme elevation with Aberrant Left Hepatic Artery transection, reports 
confirming significant hepatic necrosis, even mortality are documented. 
In presence of ALHA, dissection of hiatus during antireflux 
procedure provides more of a challenge. In laparoscopic Nissens 
fundoplication, preserving the ALHA is advocated and is accomplished 
with meticulous dissection and identification. Also according to recent 
reports, in adults safe division of this artery is necessary due to excessive 
bleeding and poses a potential risk of hepatic ischemia. 
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PHYSICAL EXAMINATION : 
TYPICAL OESOPHAGEAL SYMPTOMS : 
Heartburn (80%) – The commonest presenting symptom in GERD. 
Confined to epigastric and retrosternal areas. Can be felt as a caustic, 
stinging or burning sensation or discomfort, occurring generally post food 
intake, in supine position or bending over. There is no radiation of pain to 
the back. 
Regurgitation (54%) – Effortless reflux of gastric and/or oesophageal 
contents into the pharynx. When gastric contents spill into the 
tracheobronchial tree it can cause respiratory complications. 
Regurgitation indicates progress of disease. Regurgitation comprises 
predominantly of digested food. Undigested food is indicative of 
achalasia / diverticulm 
Predominantly epigastric abdominal pain (29%)  
Dysphagia (23%)  It is a sensation of food being stuck. It is more 
commonly felt retrosternally and is due to mechanical obstruction. 
Dysphagia is mostly for solids. It is an advanced symptom and can also 
be due to 1. primary oesophageal motility disorder 2. motility disorder 
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secondary to oesophagitis  or 3.stricture formation. Equal intensity of 
Dysphagia for solids and liquids reveal a neuromuscular cause 
Belching (15%) 
Abdominal bloating (15%) 
ATYPICAL OESOPHAGEAL SYMPTOMS : 
Coughing & Wheezing are respiratory symptoms due to the aspiration of 
gastric contents into tracheobronchial tree. Approximately 50% of 
patients with GERD-induced asthma do not experience heartburn. 
Hoarseness (21%) is due to irritation of vocal cords by gastric reflux and 
is often experienced in the morning. 
Aspiration (14%) 
Globus (4 %) 
Reflux is one of the most common causes of non cardiac chest 
pain. Reflux causing chest pain comprises of nearly 50% of the cases. 
The typical presentation of these patients is with pain resembling 
Myocardial infarction. Once a non cardiac cause of chest pain is ruled 
out, patient is started on a therapeutic high-dose of proton pump inhibitor 
(PPI’s). 
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Symptom scoring for GERD : 
GIQLI (Gastrointestinal quality of Life index): 
GIQLI is graded from 0-144 points and five sub-items:  
1. gastrointestinal symptoms  
2. emotional status  
3. physical functions  
4. social functions  
5. stress by medical treatment.  
Scores for each sub item range between 0 and 4; Higher scores 
reflect better QoL.  
Visick Classification of peptic ulcer surgical results : 
Grade I  No symptoms  
Grade II  Mild symptoms, Relieved by age  
Grade IIIa  Symptoms relieved by care but patient satisfied with results 
Grade IIIb  Symptoms not relieved by care and patient unhappy 
Grade IV  No improvement 
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Modified Visick Classification : 
Grade I  No symptoms, perfect results 
Grade II  Patient states that results are perfect, but symptoms can be 
elicited 
Grade III  Mild to moderate symptoms, patient and surgeon satisfied 
with results 
Grade IV  Mild to moderate symptoms, patient and surgeon dissatisfied  
WORKUP : 
Mandatory workup include upper GI endoscopy. 
Upper Gastrointestinal Endoscopy 
Oesophagogastroduodenoscopy (EGD) is used to define the 
anatomy, identify the presence and also severity of complications of 
reflux disease - Oesophagitis, Barrett’s oesophagus, Strictures. By taking 
the patient's history and pathologic analysis of biopsy specimens obtained 
with endoscopy, diagnosis of GERD can be made along with the grades 
and complications. Also anatomical problems like Hiatus hernia and its 
types can be identified.  
Upper GI Endoscopy is as of now the most cost-effective 
diagnostic study to diagnose GERD.  
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The location of both crura of the diaphragm, gastro oesophageal 
junction and squamo columnar junction should always be recorded. 
Non erosive oesophagitis is difficult to record endoscopically. Its 
presence can be confirmed by biopsy – showing mucosal infiltration with 
polymorphs, lymphocytes, eosinophils and balloon cells. The extension 
of relative height of mucosal papillae and hyperplasia of basal zone are 
further evidence of mucosal injury. These microscopic signs while 
providing corroborative evidence do not prove the presence of increased 
exposure to gastric juice as can occur from other forms of injury. 
Endoscopically mucosal breaks defines oesophagitis according to 
Los Angeles classification.  
Barretts oesophagus should be suspected when there is difficulty in 
visualizing the squamo columnar junction at its normal location and the 
appearance of redder more luxuriant mucosa than is normally seen in the 
lower oesophagus. Its presence is confirmatory of the reflux of gastric 
juice and must be confirmed with finding of columnar epithelium with 
intestinalization on microscopic inspection of biopsy. Multiple biopsies 
are taken cephalad to determine where Barrett’s oesophagus ends and 
normal mucosa starts. Barrett’s oesophagus can ulcerate, form stricture 
and has increased risk of malignancy and bleeding. The early signs of 
malignancy is dysplastic changes. Since they can occur randomly, we 
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should do a minimum of 4 biopsies for every 2cms. Biopsies are taken 
from the epithelial metaplasia. Due attention should be given to the 
squamo columnar junction where any mass, ulcer, nodules or 
inflammatory tissue should arouse suspicion of malignancy and warrants 
a biopsy. 
Endoscopically hiatus hernia occurs as a pouch lined by folds of 
stomach mucosal ruggae which lies 2cm or greater above the crural 
margins of the diaphragm. A sliding hiatal hernia which is prominent is 
more often than not associated with increased gastro oesophageal reflux. 
In case of a paraoesophageal hernia, due care should be taken to exclude 
any gastric ulcer or gastritis within the pouch. The J maneuver helps 
evaluate the full circumference of the mucosal lining of the herniated 
stomach.     
Oesophageal Manometry 
Oesophageal manometry aids surgical planning by measuring the 
LES pressure. This helps to identify any motility disorders. It also helps 
in evaluating Oesophageal amplitudes and propagation of oesophageal 
swallows. Oesophageal manometry also helps in correctly positioning the 
probe if needed for 24-hour pH monitoring. 
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However, as per “Guidelines for surgical treatment of 
gastroesophageal reflux disease”, done by Stefanidis D, Hope WW, 
Kohn GP in Annals of Surg. Endoscopy Nov 2010 and according to the 
study “The preoperative evaluation of patients considered for 
laparoscopic antireflux surgery” by Waring JP, Hunter JG, Oddsdottir 
M, Katz E, Am J Gastroenterology, less than 10% of manometry 
findings alter surgical planning. Also, no literature supports 
mandatory preoperative manometry testing. Rather, manometry 
may be considered in patients who do not respond to empiric medical 
treatment and have normal endoscopy findings. 
6,7,9,10,11,50
 
Ambulatory 24-Hour pH Monitoring 
24-hour pH monitoring during rest and ambulation helps to 
establish diagnosis of Gastro Oesophageal Reflux. It has a high 
sensitivity of 96% and a specificity of 95% in patients when their history 
is not conclusive and in patients where atypical symptoms dominate the 
clinical picture, or in a case of Upper GI endoscopy showing no 
complications of reflux. It quantifies the gastrooesophageal reflux and 
allows a correlation between the symptoms of reflux and the episodes of 
reflux. Either a 24-hour ambulatory oesophageal pH-meter or the 48-hour 
wireless oesophageal pH-monitor probe is used. 
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However, while pH testing is considered the criterion standard for 
diagnosis of GERD, routine use has found it to be only of marginal 
benefit. 
10,50
 This test is best used in the absence of endoscopic evidence 
of reflux or when the diagnosis is unclear according to Frantzides CT, 
Carlson MA, Madan AK, Stewart ET, Smith C. in “Selective use of 
esophageal manometry and 24-hour pH monitoring before 
laparoscopic fundoplication” Journal of American Coll Surg. 2003 and 
“Guidelines for surgical treatment of gastroesophageal reflux 
disease”, done by Stefanidis D, Hope WW, Kohn GP in Annals of Surg. 
Endoscopy Nov 2010. Thus, Patients with oesophagitis confirmed on 
endoscopy are not in need of pH monitoring for establishing a diagnosis 
of Gastro oesophageal reflux.
6,10,11
  
To conclude, the following are indications for oesophageal 
manometry and pH monitoring over 24 hours which include: 
- Persisting symptoms inspite of adequate anti secretory drugs such 
as PPI’s and  recurrence of symptoms post discontinuing 
medication in the absence of endoscopic findings and in 
investigating atypical symptoms like chest pain or asthma in 
subjects not having oesophagitis.  
Also, as of present there is no role for CT, MRI or ultrasonography in 
routinely evaluating patients with reflux disease. 
27,41,50
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Imaging in GERD : 
Plain radiography is not very useful to evaluate patients for Gastro 
oesophageal reflux, however it plays a role in evaluating lung status and 
basic anatomy. X ray chest can identify large hiatus hernias. It must be 
noted however that small hernias can be easily missed. Contrast-enhanced 
upper GI studies were the initial diagnostic radiologic test of choice in 
working up a patient with suspected GERD. Oesophageal inflammatory 
diseases and neoplasms are better detected with double-contrast study. 
However, single-contrast techniques still have more sensitivity in 
detecting structural anomalies like hiatus hernias, strictures and 
oesophageal rings. 
Delay in gastric emptying time is observed in nearly 60% of the 
patients suffering from Gastro oesophageal reflux. Patients suffering from 
a delay in gastric emptying time classically have bloating post food intake 
and fullness of abdomen besides other symptoms. In these patients 
studies which determine Gastric-emptying will be useful to evaluate 
whether delayed gastric emptying is the contributor of GERD symptoms. 
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Intraluminal Oesophageal Electrical Impedance 
Intra-luminal oesophageal electrical impedance (EEI) is a more 
recent test which detects both acidic and nonacidic reflux by measuring  
retrograde flow within the oesophagus. Gastrooesophageal reflux 
episodes which last as briefly as 15 seconds are measured 
 
This image represents concomitant intraoesophageal pH and 
oesophageal electrical impedance measurement. The vertical solid arrow 
is used to indicate commencing of a nonacid gastro oesophageal reflux 
episode. The vertical dashed arrow indicates the onset of a normal 
swallow. 
In adult studies, impedance measurements are used in conjunction 
with 24-hour intra oesophageal pH monitoring, to provide a more 
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complete picture of bolus movement within the oesophagus. EEI is not 
yet thoroughly validated and normal values for paediatric age group are 
yet to be determined. 
APPROACH CONSIDERATIONS 
Treatment of gastro oesophageal reflux disease is by a stepwise 
approach. The goal is to control symptoms, to heal the oesophagitis and 
to prevent recurrent oesophagitis or other complications.  
The treatment is based on  
(1)  Lifestyle modification  
(2)  Control of gastric acid secretion through a. Medical therapy with 
antacids / PPIs or b. Surgical treatment with corrective antireflux 
surgery.
 
Approximately 80% of patients have recurrent but non progressive 
forms of GERD which can be controlled with medications alone. 
Identifying the other 20% of patients who have the progressive form is 
important, because these patients may develop severe complications in 
future such as strictures or Barrett oesophagus. For these patients surgical 
treatment should be given as an option in earlier stage itself to avoid the 
sequelae of the disease that can have far more serious consequences.  
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By use of a self management tool by patient, eg. a self-
administered GERD Questionnaire (Gerd Q) for stratification of  patients 
will help in improving GERD management of patients in primary health 
care setting. 
Lifestyle Modification 
- Weight loss especially in obese patients 
- Avoid alcohol, chocolate, citrus juices and spicy food 
- Taking small frequent meals 
- To wait for atleast 3 hours after a meal before lying supine 
- Elevate the head end of bed by 8 inches 
Lifestyle modifications also constitute the first line of management 
in pregnant women with GERD. Patients are adviced elevation of head 
end of the bed; to avoid bending down or assuming a stooping positions; 
to consume small quantity meals with increased frequency and avoid 
intake of food(except maybe liquids) before 3 hours of bedtime. 
Pharmacologic Therapy 
1. Antacids 
Antacids were the mainstay drugs for controlling mild symptoms 
of GERD in the 1970’s and still remain effective. Antacids should be 
taken after each meal and before going to bed. 
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2. H2 receptor antagonists and H2 blockers 
H2 receptor antagonists were first-line drugs in patients suffering 
from mild to moderate symptoms with Grade I and Grade II GERD. 
Options include Ranitidine, Cimetidine, Famotidine. However, they were 
found to be effective in curing only mild oesophagitis in nearly 80% of 
patients with Gastro oesophageal reflux and also in providing 
maintenance dose to help prevent relapse. Tachyphylaxis was also 
observed, leading on to suggest that pharmacological tolerance may 
develop which causes reduction in the efficiency of these drugs in the 
long run. The H2 receptor antagonists were reversible competitive 
histamine blockers at the H2 receptor sites, especially in the parietal cells 
of gastric mucosa, where they cause inhibition of acid secretion. Being 
highly selective, they have no effect on the H1 receptors 
3. Proton Pump Inhibitors 
Proton pump inhibitors (PPIs) belong to the class of medicines that 
are ubiquitous in the day to day practice of any gastroenterologist. This 
has replaced h2–receptor antagonists in treating moderate to severe 
stomach acid reflux and are the drugs of choice for prophylaxis of GI 
injury. Their safety among other pharmacological agents has been 
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undisputed.  PPIs remain at the top among the list of widely sold drugs 
worldwide. The first PPI, Omeprazole, introduced in 1980’s is in 
WHO’s List of essential medicines.  
They are used in treating many conditions like:  
 Dyspepsia 
 Peptic ulcer disease, which also includes after endoscopic 
treatment for bleeding 
 For Helicobacter pylori eradication therapy 
 GERD – in patients having symptoms but have no findings on 
endoscopy to suggest reflux disease 
 Associated laryngo-pharyngeal reflux which causes chronic cough 
and laryngitis 
 Barrett's oesophagus 
 To treat Stress gastric ulcers and their prevention in critical care 
patients 
 Gastrinoma and other conditions which may lead on to increased 
secretion of acid. This includes Zollinger–Ellison syndrome 
Mechanism of Action: 
Proton pump inhibitors act by irreversible blockage of 
H
+
/K
+
 ATPase, of the gastric parietal cells. This is the last stage in 
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secretion of gastric acid, thus it directly causes H
+
 ion secretion into the 
lumen of the stomach, thus making it an easy target for inhibition of acid 
secretion. 
Due to the decrease in acid secretion in the stomach, faster healing 
of duodenal ulcers are promoted and pain due to indigestion 
and heartburn are reduced. Decreased quantities of gastric acid 
(hypochlorhydria) impairs protein digestion and nutrient absorption, 
especially Vitamin B12 and Calcium. 
 PPIs when given in inactive form, which when neutrally 
charged(lipophilic) can readily cross cell membranes into intracellular 
compartment with acidic environment. Here the inactive drug is 
protonated to rearrange to its active form.  
PPI”s include : 
Omeprazole 
Lansoprazole 
Rabeprazole 
Esomeprazole 
Pantoprazole  
Ilaprazole (not FDA approved as of October 2013) 
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Pharmacokinetics 
The rate of omeprazole absorption can be decreased by 
concomitant intake of food. Also, absorption of lansoprazole and 
esomeprazole is also decreased and delayed by food intake. However, 
according to reports, these pharmacokinetics have no significant impact 
on its efficacy. PPIs have a short half-life in human plasma (60–90 min), 
However, since they covalently bind to pump, their half-life of gastric 
acid secretion, inhibition is much longer. Half-life at site of action is 
roughly 24 hours.  
Effects on Vitamin and Mineral Absorption 
Iron : Though PPI’s can reduce non heme iron absorption and decrease 
iron pool replenishment, this effect has not been well demonstrated in 
clinical practice. 
Calcium : Evidence to suggest PPI’s cause increased risk osteoporotic-
related fractures is not well proven. Various studies and data on bone 
density loss and osteoporotic fractures are not convincing to suggest 
discontinuing PPIs for appropriate indications at correct doses. Also 
contrary to what was initially suggested PPIs can actually increase bone 
density by impairing osteoclastic activity, which facilitates the dissolution 
of bone matrix and its subsequent resorption. 
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Vitamin B12: Gastric acid causes absorption of B12 by initiating its 
release from dietary protein, causing B12 to bind to R protein. This B12–R 
protein complex breaks down in duodenum, causing B12 to be absorbed in 
terminal ileum. Since B12 absorption depends on stomach acid, 
theoretically, long-term PPI’s can impair their absorptive ability. 
Magnesium : Low levels of magnesium can occur in patients on PPI 
therapy which can reverse when switched to H2-receptor antagonists. 
Studies reveal a correlation between PPI use and Clostridium 
difficile infection, causing FDA to include a warning label on PPI’s.  Also 
concerns have been raised about small intestinal bacterial 
overgrowth and spontaneous bacterial peritonitis in older people taking 
PPIs and in subjects with irritable bowel syndrome on PPIs. Long-term 
use of PPI is also associated with development of benign  
polyps from fundic glands. These are not carcinogenic and resolve on 
discontinuation of PPIs. Also use of PPIs can mask gastric cancers and 
other gastric disorders. Hence physicians should be aware when 
prescribing. PPI’s have also been associated with microscopic colitis. 
Cardiovascular : 
Relationship between PPI’s and cardiovascular events are not very 
clear. PPIs with Aspirin is commonly used in cardiovascular patients for 
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gastric protection where Aspirin is given for its antiplatelet action. 
Similarly it is also done in the case of Clopidogrel. One suggested 
mechanism for this corelation is, PPIs bind and inhibit dimethylargininase 
enzyme which degrades asymmetric dimethylarginine (ADMA) causing 
increasing ADMA levels and decreasing bioavailable nitric oxide levels. 
In January 2009, the FDA issued a recommendation against the combined 
use of clopidogrel and all PPIs, subsequently revising their statement to 
recommend against potent CYP2C19 inhibitors, naming omeprazole, 
esomeprazole, and cimetidine.
 
This recommendation was based on 
several high-profile retrospective database evaluations that found higher 
cardiac event rates (stent thrombosis, myocardial infarct, and death) in 
patients who were taking clopidogrel with PPI’s than those on clopidogrel 
alone. 
In general, proton pump inhibitors are well tolerated, and the 
incidence of short-term adverse effects is relatively low. Long-term use 
of PPIs has been less studied than short-term use, and the lack of data 
makes it difficult to issue definitive statements. 
Other common adverse effects include  headache,  
nausea, diarrhea, abdominal pain, fatigue, and dizziness. Infrequent 
adverse effects include rash, itch, flatulence, constipation, anxiety, 
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and depression. Also rarely, PPI use may be associated with occurrence 
of myopathies, including the serious reaction rhabdomyolysis. 
4. Prokinetics 
Prokinetics improve oesophageal and stomach motility. It also 
increases LES pressure thereby helping to reduce gastric reflux. They 
also accelerate gastric emptying. Prokinetic agents are mostly effective 
only in patients with mild symptoms. Those with more severe symptoms 
need additional acid-suppressing medication such as PPIs. Long-term 
prokinetic agent intake should be discouraged as they have serious, even 
potentially fatal complications. Metoclopramide is a Gastrointestinal 
prokinetic agent which causes an increase in GI motility, increasing 
resting oesophageal sphincter tone and relaxing the pyloric sphincter. 
 
INDICATIONS FOR SURGICAL MANAGEMENT 
Surgical therapy for gastrooesophageal reflux today is both by 
transthoracic and transabdominal fundoplications, using either partial 
(anterior or posterior) or circumferential wraps. 
The commonest surgery performed today, both in children and 
adults is the Nissen’s floppy 360° fundoplication, by transabdominal 
approach.  First report of this procedure is in 1991, which was generally 
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well accepted and studied in adults, now Laparoscopic fundoplication is 
also gaining acceptance for use in children. 
 
Indications for fundoplication : 
- Patients with reflux symptoms not completely controlled by PPI’s. 
It is also considered in patients with GERD under control who 
desire one-time definitive treatment. 
- Barrett’s oesophagus is also an indication for surgery (whether 
suppression of acid improves the outcome or prevents progression 
of Barrett’s oesophagus remains unknown, but most authorities 
recommend complete acid suppression in patients with 
histologically proven Barrett’s oesophagus) 
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- In patients with extraoesophageal GERD manifestations like(1) 
respiratory manifestations (eg, aspiration, cough, wheezing,)  (2) 
ENT manifestations (eg, sore throat, otitis media, hoarseness of 
voice) and  (3) dental manifestations (eg, erosion of enamel) 
- Patients who are not compliant with medication 
- Postmenopausal women with osteoporosis 
- Patients having cardiac conduction defects 
- Patients who cannot afford the long term costs of medical therapy 
There have been several RCT’s over the years which have challenged 
whether surgery benefits over medical management in controlling GERD.  
According to a trial done by Spechler at the end of 10 years post 
fundoplication 62% of patients were on antireflux medications.
24   
Another randomized study by Anvari et al again emphasised the 
importance of surgery in treating GERD.
 
They have proved that at the end 
of 1 year, the outcomes and symptoms among the surgical group was 
better than that kept on long term medical management. 
17,18 
Another multicenter RCT done by Grant et al comparing surgical 
treatment with medical treatment in patients documented with GERD, 
involved individuals who were on medical management for a median of 
nearly 32 months. This study reported that at the end of 1 year, 38% of 
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those post surgery were taking reflux medication compared to 90% of the 
individuals randomized to medical management. Also, long-term results 
of laparoscopic Fundoplication have revealed that at end of 10 years, 90% 
of patients were symptom free with only a minority still having to take 
PPIs.
27 
Another Long-term followup from a multicenter, pragmatic 
randomized trial revealed that relative to pharmacotherapy, post surgical 
patients maintained better symptomatic relief in gastro oesophageal reflux 
without evidence of any adverse long-term postsurgical symptoms. 
Results of this study concluded that at the end of  5 years, nearly twice as 
many patients randomized to medical management (82%) were taking 
antireflux agents compared to those who had been randomized to surgery 
(44%). 
25,26
 
Laparoscopic fundoplication (Nissens floppy 360 degree 
fundoplication) 
Laparoscopic Nissens fundoplication is generally performed under 
GA. Five 5 to 10mm port incisions are made. The basic surgical principle 
is the fundus of the stomach being wrapped around the lower oesophagus 
creating a new valve at the level of the oesophagogastric junction. 
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The important surgical principles are as follows: 
- All around completely mobilise the fundus of stomach with or 
without division of the short gastric vessels 
- Repair of hiatus hernia 
- Narrowing the oesophageal hiatus 
- Creating a floppy 360° fundoplication over a Oesophageal bougie 
(dilator) 
Laparoscopic fundoplication generally lasts 2 - 2 1/2 hours. The 
mean postoperative hospital stay is roughly 2 days. Patients usually 
resume normal activities in 2-3 weeks. According to study, approximately 
92% of patients are fully resolved of their symptoms post surgery. 
18 
PPIs, though useful to control the acid component of reflux, does 
not completely rid the patient of bile reflux, which is a major contributor 
of Barrett’s epithelium. Subjects with Barrett’s oesophagus usually have 
lower LES pressures and comparatively poorer oesophageal peristalsis 
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than in those without Barrett’s. Hence they are also subjected to a large 
quantity of reflux. Here Nissens floppy fundoplication offers the only 
possibility to reduce reflux by recreating a competent LES. 
Partial fundoplication : 
 270 posterior – Toupet  
In modified toupet the fundus is mobilized posterior to oesophagus 
as in Nissens fundoplication. The posterior wall of the fundus on each 
side of the oesophagus is sutured to oesophagus with interrupted 2’0 or 
3’0 absorbable sutures approximately 45 degress to either side of the mid 
anterior oesophageal wall. A total of 3 interrupted sutures are placed on 
each side approximately 1cm apart resulting in a 2 cm fundoplication. 
Care should be taken to position the fundoplication on the oesophagus 
and not onto the stomach and to preserve the vagus, not entrapping it 
within the suture   
 180 anterior – Dor and  
Here the fundoplication is constructed by accentuating the angle of 
His and folding the fundus over the anterior surface of oesophagus. The 
first suture fixes the medial wall of the fundus near the Angle of His to 
the anterior aspect of the left crus. The next suture is placed between the 
fundus and left anterior aspect of the hiatus. The fundus is then folded 
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over the anterior aspect of the hiatus by placing a suture between the 
fundus and right anterior aspect of hiatus. Several additional sutures are 
placed approximately at 1cm intervals, approximating the fundus of 
stomach to the right posterolateral wall of the oesophagus and right crus 
 
 270 gastric fundoplication perfomed through chest – Belsey Mark 4 
In this procedure which is performed transthoracic the oesophagus 
is adequately mobilized to avoid tension. In situations where the 
oesophagus has shortened, aggressive mobilization does not produce a 
tension free repair. To counter this, oesophageal lengthening technique 
was done by making a tube about the diameter of the oesophagus and 
5cm in length in the lesser curvature of the stomach and constructing a 
Belsey fundoplication around the tube. This was called the Collin Belsey 
repair named after Dr. Leigh Collin and Dr. Ronald Belsey. The major 
drawback of this procedure is acid production within the tubularised 
portion of the stomach. Also this procedure is difficult to teach and has 
very less margin for error. In an experienced surgeon Mark Belsey 
operation has similar success to Nissens fundoplication. 
Complications of antireflux surgery : 
- Most common perioperative complication is early wrap herniation 
(1.3%) occurring within 48 hours of surgery. It is more common in 
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Laparoscopic than open surgeries, reason being attributable to 
opening of more tissue planes due to pneumoperitoneum and 
reduced tendency for adhesion formation in laparoscopic surgery. 
It is avoided by performing crural repair.  
- Pneumothorax & Pneumperitoneum : Pneumothorax is attributable 
to breach of either of the pleural membrane, more commonly the 
left during hiatal dissection. Chest drain insertion is rarely needed 
as Co2 rapidly dissipates following the release of 
pneumoperitoneum due to absorption and positive pressure 
ventilation. 
- As with any laparoscopic procedures hollow viscous perforation 
may occur. Oesophageal perforation may occur during passage of 
Bougie, retrooesophageal dissection or suture pull through. Late 
oesophageal perforation may be related to Diathermy use during 
mobilization. Gastric perforations usually occur due to excessive 
traction on the fundus for retraction purposes.  
- Hemorrhage during surgery arises mostly from Short gastric 
vessels or spleen. Retractor trauma to liver, Injury to left inferior 
phrenic vein, Aberrant Left hepatic artery and Inferior vena cava 
are rare causes. Similarly cardiac tamponade due to ventricular 
trauma has also been reported.  
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- Slipped or Misplaced Nissen - A "slipped Nissen" occurs when the 
body of stomach intussuscepts through the fundoplication, creating 
an hourglass deformity where both above and below the wrap 
stomach is residing. This complication is associated with severe 
regurgitation and reflux, since the pouch of stomach residing above 
fundoplication can trap food and serves as a reservoir for acid-rich 
refluxate below an incompetent lower esophageal sphincter (LES). 
Also, the wrap can get misplaced around upper stomach rather than 
oesophagus, creating an hourglass defect where the wrap is below 
the diaphragmatic hiatus and the upper stomach and 
gastrooesophageal junction above the diaphragmatic hiatus. 
- Twisted Fundoplication – This occurs when the short gastric 
vessels are not divided,  although it can also happen when they are 
divided. Here a portion of anterior stomach wall is pulled from the 
left around the oesophagus posteriorly and sutured to another 
portion of the anterior stomach wall that has been pulled from a 
spot low on the greater curvature. This can create tension at the 
GEJ which causes rotation of the distal oesophagus with the 
fundoplication causing a spiral-type deformity seen in retroflexion 
of an endoscope. This deformity usually can produce dysphagia 
and severe postoperative gas bloat that do not respond to dilatation. 
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The fundoplication valve is twisted by the fundus attempting to 
unwind itself 
- Post operative gastrooesophageal Reflux disease : Post operative 
gastro oesophageal reflux and dysphagia are related to the length of 
myotomy and type of antireflux procedure and not to the approach 
for the procedure (open or laparoscopic) It is usually mild and can 
be managed medically 
- Post operative dysphagia   
- Weight loss 
- Gas bloat 
One complication which has been virtually eliminated post the 
Laparosopic era is splenic injury 
 “Medical versus surgical management for gastro-oesophageal 
reflux disease in adults” done by Wileman SM, McCann S, Grant AM, 
Krukowski ZH, Bruce J. , University of Aberdeen, Foresterhill, 
Aberdeen, UK by comparing the effects of medical management versus 
laparoscopic fundoplication surgery using health-related and GORD-
specific quality of life (QOL) in adults with GORD, concluded a 
Significant decrease in antacid medication use (97% vs 19%) and that 
laparoscopic fundoplication surgery is more effective than medical 
69 
 
management for the treatment of GORD atleast in the short to medium 
term. Surgery does carry some risk but the benefits outweigh the risks 
12
 
 “Quality of life following laparoscopic Nissen fundoplication: 
Assessing short-term and long-term outcomes” done by Ilmo 
Kellokumpu, Markku Voutilainen, Caj Haglund, Martti Färkkilä, Peter J 
Roberts, Hannu Kautiainen, published in world journal of 
Gastroenterology, Jun 2013 done for two hundred and forty-seven 
patients for short-term analysis following endoscopy showed cure of 
Gastroesophageal reflux disease in 98.4% of patients three months after 
surgery. New-onset dysphagia was encountered postoperatively in 13 
patients (6.7%); 95% reported that the outcome was better after 
antireflux surgery than with preoperative medical treatment. 
28
 
 “Comparative Effectiveness of Management Strategies For 
Gastroesophageal Reflux Disease” was done by Stanley Ip, MD, Joseph 
Lau, MD in 2005 Dec, Tufts-New England Medical Center EPC, Boston, 
Massachusetts. They did a 10-year study of open fundoplication 
(Spechler) included mostly patients with complicated GERD who 
received non-PPI based medical interventions at enrollment, a 5-year 
study of open fundoplication (Lundell) included patients whose 
symptoms and oesophagitis responded to PPI treatment, and a 1-year 
study of laparoscopic fundoplication (Mahon) included mostly patients 
70 
 
with GERD symptoms but without complications who had been treated 
with PPIs for at least 3 months. The two studies of open fundoplication 
(Spechler and Lundell) reported similar degree of improvement in 
symptoms compared with baseline in the medical group and significant 
reduction in oesophageal acid exposure in the surgical group compared to 
medical therapy at three months in the study by Mahon and one year in 
the study by Spechler. 
2
 
“Surgical Management of Extra-esophageal Reflux Disease” 
done during the  Grand Rounds Presentation in the Department of 
Otolaryngology in The University of Texas Medical on January 29, 2013 
by Andrew Coughlin, MD,. Michael Underbrink, MD and Francis B. 
Quinn, Jr., MD say that a conservative approach with empiric therapy can 
be helpful prior to ordering expensive tests. If patients continue to be 
symptomatic then a formal workup with EGD to rule reflux is instituted. 
Other tests like impedance and manometry should be reserved for patients 
with more severe oesophageal problems. Referral to surgeons for 
Nissen’s fundoplication should be considered in all patients with 
documented reflux who are resistant to therapy, have proven 
complications or do not wish to take medications for life. 
31
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“Symptoms and Antireflux Medication Use Following 
Laparoscopic Nissen Fundoplication outcome at 1 and 4 Years” 
published by Mark Bloomston, MD, William Nields, BA, Alexander S. 
Rosemurgy, MD published in JSLS, In this study one hundred patients 
undergoing laparoscopic Nissen fundoplication between 1992 and 1997 
were asked, at 1 to 2 years and 4 to 6 years postoperatively, to grade their 
symptoms on a scale of 1 (mild) to 10(severe). Patients were also queried 
as to the number/cost of antacid medications used before and after 
fundoplication. Laparoscopic Nissen fundoplication results in a 
significant reduction in the symptoms of reflux and the use of antacid 
medications with a high degree of patient satisfaction. Although some 
patients return to antacid medications at late follow-up, they continue to 
have few symptoms and are pleased with their outcomes. 
27
  
 “Laparoscopic Nissen fundoplication - 200 consecutive cases”, 
done by D C Gotley, B M Smithers, M Rhodes, B Menzies, F J Branicki, 
L Nathanson published in GUT journal. 200 patients operated between 
1991 and 1994 were included in the study. Pre-operative assessment 
included symptom score, endoscopy, manometry and 24 hour pH 
monitoring of the oesophagus. Patients were evaluated at three and 12 
months after surgery. They came to the conclusion Laparoscopic Nissen 
fundoplication is a safe and effective procedure for gastro-oesophageal 
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reflux disease. With experience, the duration of operation falls and the 
hospital stay is shorter. Short term symptomatic and pH results show a 
consistent improvement by surgery. 
36 
According to a scientific paper published in JSLS – “Symptoms 
and Antireflux Medication Use Following Laparoscopic Nissen 
Fundoplication: Outcome at 1 and 4 Years” by Mark Bloomston, MD, 
William Nields, BA, Alexander S. Rosemurgy, MD, Laparoscopic Nissen 
fundoplication results in Significant decrease in antacid medication use 
(97.3% vs 18.4%) in a significant reduction in the symptoms of reflux 
and the use of antacid medications with a high degree of patient 
satisfaction. Although some patients return to antacid medications at late 
follow-up, they continue to have few symptoms and are pleased with their 
outcomes.
34 
Another “Prospective Study of Laparoscopic Nissen 
Fundoplication in a Community Hospital and Its Effect on Typical, 
Atypical, and Nonspecific Gastrointestinal Symptoms”published in 
JSLS done by Mark E. Ranson, MD, Amanda Danielson, MS, J. Gary 
Maxwell, MD, James A. Harris, MD studied 91 patients and long-term 
data on 84 patients were studied. Overall long-term improvement was 
98%. Regarding typical symptoms, the greatest improvement occurred in 
heartburn and regurgitation. Regarding atypical symptoms, the greatest 
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improvement occurred in cough and sore throat. In this study Bloating, 
nausea, and diarrhea showed no significant change between preoperative 
and postoperative surveys. Mild weight loss was common. 
According to another scientific paper published in JSLS, 
“Postoperative Gastrointestinal Complaints After Laparoscopic 
Nissen Fundoplication” done by Constantine T. Frantzides, MD, PhD, 
Mark A. Carlson, MD, John G. Zografakis, MD, Ronald E. Moore, MD, 
Tallal Zeni, MD, Atul K. Madan, MD patients who have undergone 
laparoscopic Nissen fundoplication for gastrooesophageal reflux disease 
will have gastrointestinal complaints mostly during the initial 3 
postoperative months. Nearly all of these patients, aproximately 95% 
have resolved symptomatology after 3 months. Those with persistent 
symptoms after 3 months warrant evaluation for operative failure. 
32
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MATERIALS AND METHODS 
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MATERIALS  
A Prospective / Retrospective study conducted in PSG Institute of 
Medical Sciences and Research to assess whether Laparoscopic 
fundoplication really improves the quality of life compared to medical 
management and to assess the usefulness of surgery based on risk vs 
benefit ratio by comparison of their preoperative and postoperative 
Quality of  life with a questionnaire and endoscopic findings in 31 
patients 
QUESTIONNAIRE  
NAME:  
AGE:  
SEX:  
ADDRESS:  
 
IP NO/ OP NO: 
DOA: 
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DOS: 
DOD: 
PRE OPERATIVE: 
HISTORY (ONSET, DURATION AND COMPLAINTS) : 
 
 
PAST / PERSONAL H/O: 
 
MEDICATIONS HE/SHE IS TAKING FOR THE COMPLAINTS 
 
PHYSICAL EXAMINATION 
 
UGI SCOPY REPORT: 
 
USG ABDOMEN (IF DONE) : 
 
OESOPHAGEAL MANOMETRY(IF DONE)  
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COMPLAINTS  Graded on GERD - HRQL ( HEALTH RELATED 
QUALITY OF LIFE SCALE) 
 HEARTBURN (each 1 point) 
On lying down 
On standing position 
After meals 
Does it disturb sleep 
 DIFFICULTY IN SWALLOWING 
 PAIN ON SWALLOWING 
 BLOATY FEELING 
 ABDOMINAL PAIN 
(2nd-5th) 1-5 (TICK WHATEVER IS APPLICABLE) points 
 0 - NO SYMPTOMS 
 1 - SYMPTOMS PRESENT, NOT BOTHERSOME 
 2 - SYMPTOMS PRESENT, NOT EVERYDAY BOTHERSOME 
 3 - SYMPTOMS PRESENT, EVERYDAY BOTHERSOME 
 4 - SYMPTOMS AFFECTING DAILY ACTIVITIES 
78 
 
 5 - SYMPTOMS INCAPACITATING 
Scoring (MAXIMUM OF 29, MINIMUM 0 ) – PROGNOSIS BETTER, 
THE LESSER THE SCORE  
ANTIREFLUX MEDICATION (1 point for each) 
 H2 blockers   
 Antacids   
 Ca channel blockers  
 Anti anxiety drugs  
 Prokinetics   
 
Type of Study  
Observational, Prospective and Retrospective 
Inclusion Criteria  
Clinical reflux symptoms 
UGI endoscopy 
Exclusion Criteria   
H/o previous oesophageal surgery  
Complicated reflux (eg. Ulcer, Short oesophagus) 
METHODOLOGY  
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 In this study 30 patients who had clinical symptoms of gastro 
oesophageal reflux were included.  
Informed consent was obtained detailing the study process, need 
for the study and its benefits, elaborately. The history was recorded by the 
principal investigator.  
The questionnaire was filled diligently by the principal 
investigator. 
All 31 patients were subjected to clinical examination by the 
principal investigator in an unbiased manner. 
Their Upper GI endoscopy findings were recorded, along with 
Oesophageal manometry and USG abdomen as and when required. 
Clinical symptoms of patients, especially those refractory to long term 
medical management and findings with UGI scopy played a role in 
patient selection for surgery. 
After the patients underwent laparoscopic fundoplication, re 
evaluation of their symptoms and their quality of life was done with 
History, clinical examination and questionnaire and repeat UGI scopy. 
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Pre and Post operative endoscopy pictures taken in our hospital 
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OBSERVATION 
Analysis of Data:  
A total of 31 cases were included in the study 
1 patient did not present for follow up 
 For 30 cases informed written consent was obtained 
For all 30 cases preoperative and post operative history was elicited and 
questionnaire completed 
For 31 cases preoperative UGI scopy done  
For 5 cases preoperative Oesophageal manometry was done 
For 28 patients post operative USG was done. (2 patients were not willing 
for follow up USG) 
Pre operatively all 31 patients were taking either PPI’s, Antacids, 
Prokinetics or the combination of above.  Post operatively 16 patients 
were still taking PPI’s. (It must be noted that there was marked relief of 
symptoms, with medication post Surgery compared to prior to surgery, in 
which a majority of patients were refractory to medical management). 
This compares favourably with the international standard of patients on 
pre and post surgical medication) 
92 
 
According to the Health Related Quality of Life questionnaire, the relief 
of symptoms post surgical management is 93% which again compares 
favourably with international standards 
 
According to UGI scopy findings  
10 subjects had Grade 1 reflux oesophagitis post surgery 
3 patients among them had antral gastritis 
1 patient had erosive gastritis 
3 patients had prolapse gastropathy 
1 patient had a small hiatal hernia post surgery 
Rest of 27 patients had intact fundoplication wrap 
These recurrence rates are on par or better in comparison with 
international standards 
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DISCUSSION 
A prospective / retrospective study of evaluation of 30 patients 
undergoing laparoscopic nissens fundoplication in PSG hospitals was 
done and it infers the following.   
This study expands from previous research done in evaluating the 
patients who had undergone laparoscopic Nissens fundoplication and we 
have concluded our experience with our study population which exhibits 
particular similarities and differences compared to that of international 
research data available 
1. Post operative improvement and relief of heartburn ranged from 
complete relief to 90% (at the end of a ten year study). This 
compares favourably with our data where our patients give 96.3% 
improvement in the relief of heart burn post fundolication 
13,45,46,47,55
 
2. HRQL (quality of life score) improvement as per our study was 
93.2%. This again compares favourably with international 
standards which ranges between 91% to 95% according to various 
studies.
 14,16,23,24,28,32, 55
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3. 10% of our patients had post operative dysphagia. This is lesser 
than international literature which reports between 25-39%.
16,31,32,52
 
Proper surgical technique plays a role in this. 
4. Recurrence of Hiatal hernia as per our study was 3.7%. This was 
again lesser than international standards which was between 10-
12%. Proper surgical technique plays a role in preventing 
recurrence. It is also noted that our study population and period 
was relatively smaller than international literature 
34,47
 
5. The Percentage of patients still having to take post operative 
medication according to our study was 25.4%, which is relatively 
higher than international literature which reports between 14-23% 
25,27,29
. However these patients now respond to PPI’s unlike some 
of the preoperative category who were refractory to PPI’s 
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CONCLUSION 
The advent and advances in Laparoscopic Fundoplication plays a 
pivotal role in the surgical treatment of clinically significant GERD not 
resolving with medical management and also in patients responding to 
PPI’s but not desiring long term medical management. 
It is also worthwhile mentioning that proper surgical techniques 
like completely mobilizing the fundus and GE junction, creating a floppy 
fundoplication, division of Short gastric vessels and right crus first 
approach led to decreased post operative complications and recurrences.   
Inspite of our study numbers being small and of shorter duration, 
we can conclude that our overall experience in evaluation of the patients 
who had undergone laparoscopic Nissen’s fundoplication, showed a 
significant reduction and relief of reflux symptoms. The proportion of 
patients who had to rely on medication post surgery was also significantly 
less than prior to surgery. Even if the patients relying on medication were 
slightly higher than international standards it is worth noting that post 
surgery these patients have relief through PPI’s compared to those prior 
to surgery who were refractory to medical management.  
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Also repeat UGI scopy showed Grade 1 oesophagitis in 
approximately 1/3 of those operated, but most of them were 
asypmtomatic. Also patient satisfaction concluded from the study was 
very good and we thoroughly recommend Laparoscopic Fundoplication 
to all those patients having chronic and refractory Reflux disease. 
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PROFORMA 
QUESTIONNAIRE : 
NAME:  
AGE:  
SEX:  
ADDRESS:  
 
IP NO/ OP NO: 
DOA: 
DOS: 
DOD: 
 
PRE OPERATIVE: 
HISTORY (ONSET, DURATION AND COMPLAINTS) : 
 
PAST / PERSONAL H/O: 
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MEDICATIONS HE/SHE IS TAKING FOR THE COMPLAINTS 
 
PHYSICAL EXAMINATION 
 
UGI SCOPY REPORT: 
 
USG ABDOMEN (IF DONE) : 
 
OESOPHAGEAL MANOMETRY(IF DONE)  
 
COMPLAINTS  Graded on GERD - HRQL ( HEALTH RELATED 
QUALITY OF LIFE SCALE) 
 HEARTBURN (each 1 point) 
On lying down 
On standing position 
After meals 
Does it disturb sleep 
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 DIFFICULTY IN SWALLOWING 
 PAIN ON SWALLOWING 
 BLOATY FEELING 
 ABDOMINAL PAIN 
 (2nd-5th) 1-5 (TICK WHATEVER IS APPLICABLE) points 
 0 - NO SYMPTOMS 
 1 - SYMPTOMS PRESENT, NOT BOTHERSOME 
 2 - SYMPTOMS PRESENT, NOT EVERYDAY BOTHERSOME 
 3 - SYMPTOMS PRESENT, EVERYDAY BOTHERSOME 
 4 - SYMPTOMS AFFECTING DAILY ACTIVITIES 
 5 - SYMPTOMS INCAPACITATING 
 
Scoring (MAXIMUM OF 29, MINIMUM 0 ) – PROGNOSIS BETTER, 
THE LESSER THE SCORE  
ANTIREFLUX MEDICATION (1 point for each) 
 H2 blockers   
 Antacids   
 Ca channel blockers  
 Anti anxiety drugs  
 Prokinetics   
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INTRODUCTION 
 
Over years the effective treatment for GERD has been antireflux medication 
and surgery. Patients who were not improving on medical therapy or are not 
conducive are nowadays surgically treated. This technique was originally 
pioneered by Rudolf Nissen. In a young male patient with penetrating oesophageal 
ulcer he did the first fundoplication to protect the oesophagogastric anastamosis . 
As he followed up the patient he noticed that the patient's reflux symptoms were no 
more present. Nissen again reattempted his fundoplication on a male patient with a 
paraesophageal hernia which had incarcerated. It produced excellent clinical 
results. Eventually he published the first description of his surgical procedure in 
1956, which turned out to be the birthchild of the current era of antireflux surgery. 
In original Nissen’s fundoplication, he united the posterior wall of the 
stomach with the anterior wall completely around the fundus of the stomach to 
provide a full 360-degree wrap of 4-5cm around the lower esophagus. One or two 
stitches should include the wall of the esophagus to prevent slippage of the cardia. 
In Nissen-Rossetti’s modification of the original fundoplication, he used only the 
anterior wall of the fundus and constructed a 360-degree wrap enclosing the distal 
oesophagus. In the initial Nissen-Rossetti modification he did not divide the short 
gastric vessels. However, when a tension-free wrap could not be obtained, the short 
gastric vessels were sacrificed. The role of Operative treatment for Gastro 
Oesophageal Reflux Diseases and Hiatus Hernias have changed dramatically 
during the 90’s. The driving force behind increased surgical numbers is the 
development of minimal invasive surgery. 
3,4,5
  
Although the techniques of Antireflux surgery has not changed, the approach 
has become more acceptable to the patient and referring physician because of small 
incisions, relatively short hospital stay and lack of post operative pain when 
compared to open approach. 
 
Aims and Objective  
 
Primary Aims :  Assessment of the quality of life post surgery with a disease 
specific questionnaire and to assess the degree of improvement 
UGI scopy findings pre and post surgery  
Secondary Aims : To see if any patient is still having to rely on PPI’s  
Any complications post surgery(if any) 
 
Justification of the study : To assess whether Laparascopic fundoplication really 
improves the quality of life compared to medical manaement and to assess the 
usefulness of surgery based on risk vs benefit ratio 
 
MATERIALS  
A Prospective / Retrospective study conducted in PSG Institute of Medical 
Sciences and Research to assess whether Laparoscopic fundoplication really 
improves the quality of life compared to medical management and to assess the 
usefulness of surgery based on risk vs benefit ratio by comparison of their 
preoperative and postoperative Quality of  life with a questionnaire and endoscopic 
findings in 31 patients 
QUESTIONNAIRE  
NAME:  
AGE:  
SEX:  
ADDRESS:  
 
IP NO/ OP NO: 
DOA: 
DOS: 
DOD: 
PRE OPERATIVE: 
HISTORY (ONSET, DURATION AND COMPLAINTS) : 
 
 
PAST / PERSONAL H/O: 
 
MEDICATIONS HE/SHE IS TAKING FOR THE COMPLAINTS 
 
PHYSICAL EXAMINATION 
 
UGI SCOPY REPORT: 
 USG ABDOMEN (IF DONE) : 
 
OESOPHAGEAL MANOMETRY(IF DONE)  
 
COMPLAINTS  Graded on GERD - HRQL ( HEALTH RELATED 
QUALITY OF LIFE SCALE) 
 HEARTBURN (each 1 point) 
On lying down 
On standing position 
After meals 
Does it disturb sleep 
 DIFFICULTY IN SWALLOWING 
 PAIN ON SWALLOWING 
 BLOATY FEELING 
 ABDOMINAL PAIN 
(2nd-5th) 1-5 (TICK WHATEVER IS APPLICABLE) points 
 0 - NO SYMPTOMS 
 1 - SYMPTOMS PRESENT, NOT BOTHERSOME 
 2 - SYMPTOMS PRESENT, NOT EVERYDAY BOTHERSOME 
 3 - SYMPTOMS PRESENT, EVERYDAY BOTHERSOME 
 4 - SYMPTOMS AFFECTING DAILY ACTIVITIES 
 5 - SYMPTOMS INCAPACITATING 
Scoring (MAXIMUM OF 29, MINIMUM 0 ) – PROGNOSIS BETTER, THE 
LESSER THE SCORE  
ANTIREFLUX MEDICATION (1 point for each) 
 H2 blockers   
 Antacids   
 Ca channel blockers  
 Anti anxiety drugs  
 Prokinetics   
 
Type of Study  
Observational, Prospective and Retrospective 
Inclusion Criteria  
Clinical reflux symptoms 
UGI endoscopy 
Exclusion Criteria   
H/o previous oesophageal surgery  
Complicated reflux (eg. Ulcer, Short oesophagus) 
METHODOLOGY  
 In this study 30 patients who had clinical symptoms of gastro oesophageal 
reflux were included.  
Informed consent was obtained detailing the study process, need for the 
study and its benefits, elaborately. The history was recorded by the principal 
investigator.  
The questionnaire was filled diligently by the principal investigator. 
All 31 patients were subjected to clinical examination by the principal 
investigator in an unbiased manner. 
Their Upper GI endoscopy findings were recorded, along with Oesophageal 
manometry and USG abdomen as and when required. Clinical symptoms of 
patients, especially those refractory to long term medical management and findings 
with UGI scopy played a role in patient selection for surgery. 
After the patients underwent laparoscopic fundoplication, re evaluation of 
their symptoms and their quality of life was done with History, clinical 
examination and questionnaire and repeat UGI scopy. 
 
  RESULTS 
Analysis of Data:  
A total of 31 cases were included in the study 
1 patient did not present for follow up 
 For 30 cases informed written consent was obtained 
For all 30 cases preoperative and post operative history was elicited and 
questionnaire completed 
For 31 cases preoperative UGI scopy done  
For 5 cases preoperative Oesophageal manometry was done 
For 28 patients post operative USG was done. (2 patients were not willing for 
follow up USG) 
Pre operatively all 31 patients were taking either PPI’s, Antacids, Prokinetics or 
the combination of above.  Post operatively 16 patients were still taking PPI’s. (It 
must be noted that there was marked relief of symptoms, with medication post 
Surgery compared to prior to surgery, in which a majority of patients were 
refractory to medical management). This compares favourably with the 
international standard of patients on pre and post surgical medication) 
According to the Health Related Quality of Life questionnaire, the relief of 
symptoms post surgical management is 93% which again compares favourably 
with international standards 
According to UGI scopy findings  
10 subjects had Grade 1 reflux oesophagitis post surgery 
3 patients among them had antral gastritis 
1 patient had erosive gastritis 
3 patients had prolapse gastropathy 
1 patient had a small hiatal hernia post surgery 
Rest of 27 patients had intact fundoplication wrap 
These recurrence rates are on par or better in comparison with international 
standards 
DISCUSSION 
A prospective / retrospective study of evaluation of 30 patients undergoing 
laparoscopic nissens fundoplication in PSG hospitals was done and it infers the 
following.   
This study expands from previous research done in evaluating the patients 
who had undergone laparoscopic Nissens fundoplication and we have concluded 
our experience with our study population which exhibits particular similarities and 
differences compared to that of international research data available 
1. Post operative improvement and relief of heartburn ranged from complete 
relief to 90% (at the end of a ten year study). This compares favourably with 
our data where our patients give 96.3% improvement in the relief of heart 
burn post fundolication 
13,45,46,47,55
 
2. HRQL (quality of life score) improvement as per our study was 93.2%. This 
again compares favourably with international standards which ranges 
between 91% to 95% according to various studies.
 14,16,23,24,28,32, 55
 
 
3. 10% of our patients had post operative dysphagia. This is lesser than 
international literature which reports between 25-39%.
16,31,32,52
 Proper 
surgical technique plays a role in this. 
4. Recurrence of Hiatal hernia as per our study was 3.7%. This was again 
lesser than international standards which was between 10-12%. Proper 
surgical technique plays a role in preventing recurrence. It is also noted that 
our study population and period was relatively smaller than international 
literature 
34,47
 
5. The Percentage of patients still having to take post operative medication 
according to our study was 25.4%, which is relatively higher than 
international literature which reports between 14-23% 
25,27,29
. However these 
patients now respond to PPI’s unlike some of the preoperative category who 
were refractory to PPI’s 
 
CONCLUSION 
The advent and advances in Laparoscopic Fundoplication plays a pivotal 
role in the surgical treatment of clinically significant GERD not resolving with 
medical management and also in patients responding to PPI’s but not desiring long 
term medical management. 
It is also worthwhile mentioning that proper surgical techniques like 
completely mobilizing the fundus and GE junction, creating a floppy 
fundoplication, division of Short gastric vessels and right crus first approach led to 
decreased post operative complications and recurrences.   
Inspite of our study numbers being small and of shorter duration, we can 
conclude that our overall experience in evaluation of the patients who had 
undergone laparoscopic Nissen’s fundoplication, showed a significant reduction 
and relief of reflux symptoms. The proportion of patients who had to rely on 
medication post surgery was also significantly less than prior to surgery. Even if 
the patients relying on medication were slightly higher than international standards 
it is worth noting that post surgery these patients have relief through PPI’s 
compared to those prior to surgery who were refractory to medical management.  
 
Also repeat UGI scopy showed Grade 1 oesophagitis in approximately 1/3 of 
those operated, but most of them were asypmtomatic. Also patient satisfaction 
concluded from the study was very good and we thoroughly recommend 
Laparoscopic Fundoplication to all those patients having chronic and refractory 
Reflux disease. 
 
REVIEW OF LITERATURE 
BIBLIOGRAPHY 
1. “Four year follow-up of a randomised controlled trial comparing open 
and  laparoscopic Nissen’s fundoplication in children” Maurizio Pacilli, 
Simon Eaton, Merrill McHoney, Edward M Kiely, David P Drake, Joseph I 
Curry, Keith J Lindley, Agostino Pierro, Department of Surgery, Institute of 
Child Health and Great Ormond Street Hospital, University College London, 
London, UK Received 18 April 2013, Revised 14 January 2014, Accepted 
19 January 2014, Published Online First. 14 February 2014 
2.  “Comparison of long-term outcome of laparoscopic and conventional  
Nissen fundoplication: a prospective randomized study with an 11-year 
follow-up”. By Salminen PT, Hiekkanen HI, Rantala AP,et al.Ann Surg 
2007;246:2016. 
3.  “Laparoscopic or conventional Nissen fundoplication for gastro-
oesophageal reflux disease: randomised clinical trial”. The Netherlands 
Antireflux Surgery Study Group. Bais JE, Bartelsman JF, Bonjer HJ, et al. 
Lancet 2000;355:170–4. 
4.  “Five-year subjective and objective results of laparoscopic and 
conventional Nissen fundoplication: a randomized trial.” 16 Draaisma 
WA, Rijnhart-De Jong HG, Broeders IA, et al. Ann Surg 2006;244:34–41. 
5.  “Randomized clinical trial of laparoscopic versus open fundoplication 
for gastro-oesophageal reflux disease.”17 Ackroyd R, Watson DI, Majeed 
AW, et al.  Br J Surg 2004;91:975–82. 
 
6.  “Guidelines for Surgical Treatment of Gastroesophageal Reflux 
Disease”. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardon WS, 
Fanelli RD. Surg Endosc. 2010;24:2547-2669 
7.   “The preoperative evaluation of patients considered for laparoscopic 
antireflux surgery.” Waring JP, Hunter JG, Oddsdottir M, Wo J, Katz E. 
Am J Gastroenterol. Jan 1995;90:35-38.  
8. “Oesophageal motility in reflux disease before and after fundoplication: 
a prospective, randomized, clinical and manometric study”. Fibbe C, 
Layer P, Keller J, Strate U, Emmermann A, Zornig C. Gastroenterology. 
2001;121:5-14.  
9. “Oesophageal manometry and clinical outcome after laparoscopic 
Nissen fundoplication” Yang H, Watson DI, Kelly J, Lally CJ, Myers JC, 
Jamieson GG.. J Gastrointest Surg. 2007;11:1126-1133.  
10. “Selective use of esophageal manometry and 24-hour pH monitoring 
before laparoscopic fundoplication”. Frantzides CT, Carlson MA, Madan 
AK, Stewart ET, Smith C. J Am Coll Surg. 2003;197:358-363.  
11. “Medical versus surgical management for gastro-oesophageal reflux disease 
(GORD) in adults”. Wileman SM1, McCann S, Grant AM, Krukowski 
ZH, Bruce J.Health Services Research Unit, University of Aberdeen, 
Foresterhill, Aberdeen, UK, AB25 2ZD. 
12.  “Laparoscopic Nissen Fundoplication in Korean Patients with 
Gastroesophageal Reflux Disease” Sang Kuon Lee and Eung Kook Kim. 
Department of Surgery, The Catholic University of Korea, Seoul, Korea. 
Yonsei Med J 50(1):89 - 94, 2009.  DOI 10.3349/ymj.2009.50.1.89 
13.  “Nissen fundoplication for gastroesophageal reflux disease” DeMeester 
TR, Bonavina L, Albertucci M. Ann Surg 1986; 204: 9-20. 
14.  “The floppy Nissen fundoplication: effective long-term control 
of pathologic reflux.”  Donahue PE, Samelson S, Nyhus LM, Bombeck T. 
Arch Surg 1985; 120: 663-8. 
15. “Minimising the side effects of antireflux surgery”. DeMeester TR, Stein 
HJ. WorldJ7 Surg 1992; 16: 335-6.  
16.  “Fate of Nissen fundoplication after twenty years. A clinical, endoscopic 
and functional analysis.”  Luostarinen MES, Isolauri J, Laitinen J, 
Koskinen M, Keyrilainen 0, Markkula H, et al.Gut 1993; 34: 1015-20. 
17.  “Laparoscopic Nissen fundoplication: technique and preliminary 
results.”6 Cadiere GB, Houben JJ, Bruyns J, Himpens J, Panzer JM, Gelin 
M. Br Jt Surg 1994; 81: 400-3. 
18.  “Laparoscopic Nissen fundoplication: operative results and 
short-term follow-up.” Bittner HB, Meyers WC, Brazer SR, Pappas TN. 
Am Jf Surg 1994; 167: 193-8. 
19.  “The laparoscopic Nissen fundoplication. In: Paterson-Brown S, 
Garden J, eds. Principles and practice of surgical laparoscopy.” Weerts 
JM, Dallemagne B, Jehaes C, Markiewicz S, Lombard R. London: 
Churchill-Livingstone, 1994: 264-8. 
20.  “Laparoscopic fundoplication for gastro-oesophageal reflux.” Watson 
DI, Reed MWR, Stoddard CJ, Johnson AG. Ann R Coil Surg Engl 1994; 76: 
264-8. 
21.  “Laparoscopic Nissen fundoplication: assessment of early results of 
surgical therapy.” Salky B, Edye M, Cohen L, Jaffin B. SurgEndosc 1994; 
8: 475. 
22.  “Quality of life and surgical outcome after laparoscopic Nissen 
and Toupet fundoplication: one-year follow-up.” Kamolz T, Bammer T, 
Wykypiel H Jr, Pasiut M, Pointner R. Endoscopy. 2000;32:363-368. 
23.  “Measuring improved quality of life after laparoscopic Nissen 
fundoplication.” Rattner DW. Surgery. 2000;127:258-263. 
24.  “Five- to eight year outcome of the first laparoscopic Nissen 
fundoplications” Bammer T, Hinder RA, Klaus A, Klingler PJ. 
 J Gastrointest Surg. 2001;5:42-48. 
25.  “Intermediate follow-up of laparoscopic anti-reflux surgery.” Trus TL, 
Laycock WS, Branum G, Waring JP, Mauren S, Hunter JG.  Am J Surg. 
1996;171:32-35. 
26.  “Laparoscopic Nissen fundoplication - Antireflux Medication Use 
Following Laparoscopic Nissen Fundoplication: Outcome at 1 and 4 
Years” Hinder RA, Filipi CJ, Wetscher G, Neary P, DeMeester TR, Perdikis 
G. Bloomston M et al. 218 JSLS (2003)7:211-218 
27.  “Quality of life and antireflux medication use following laparoscopic 
Nissen fundoplication.” Bloomston M, Zervos EE, Gonzalez R, Albrink 
MH, Rosemurgy AS. Am Surg. 1998;64: 509-514. 
28.  “Long-term outcome of  medical and surgical therapies for 
gastroesophageal reflux disease: follow-up of a randomized controlled 
trial.” Spechler SJ, Lee E, Ahnen D, et al. JAMA. 2001;285:2331-2338. 
29.  “Management of GERD: medical vs. surgical. Semin Gastrointest 
Disease.”Kahrilas PJ. 2001;12:3-15. 
 
30.  “Analysis and surgical treatment of persistent dysphagia after Nissen 
fundoplication.”  Bais JE, Wijnhoven BP, Masclee AA, Smout AJ, 
Gooszen HG. Br J Surg. 2001;88:569-576. 
31.  “Postoperative Gastrointestinal Complaints After Laparoscopic Nissen 
Fundoplication”  Constantine T. Frantzides, MD, PhD, Mark A. Carlson, 
MD, John G. Zografakis, MD, Ronald E. Moore, MD, Tallal Zeni, MD, Atul 
K. Madan, MD, JSLS Scientific Paper 
32.  “The floppy Nissen fundoplication. Effective long-term control of 
pathologic reflux.” Donahue PE, Samelson S, Nyhus LM, Bombeck CT.  
Arch Surg. 1985;120(6):663– 668. 
33.  “A study of 362 consecutive laparoscopic Nissen fundoplications.” 
Surgery. Frantzides CT, Richards C. 1998;124(4):651– 654; discussion 654–
655. 
34.  “Laparoscopic Nissen repair: indications, techniques and long term 
benefits.” Fuchs KH, Breithaupt W, Fein M, Maroske J, Hammer I. 
Langenbecks Arch Surg. 2005;390:197–202. Epub 2004 Jul 3. 
35.  “Five-year comprehensive outcomes evaluation in 181 patients after 
laparoscopic Nissen fundoplication.” Anvari M, Allen C. J Am Coll Surg. 
2003;196(1):51–57; discussion 57–58; author reply 58–59. 
36.  “Results of laparoscopic Nissen fundoplication at 2–8 years after 
surgery.” Booth MI, Jones L, Stratford J, Dehn TC.  Br J Surg. 
2002;89(4):476–481. 
37. “Predictability of dysphagia after laparoscopic nissen fundoplication.” 
Kamolz T, Bammer T, Pointner R. Am J Gastroenterol. 2000;95(2):408–
414. 
38. “Functional outcome after laparoscopic or open Nissen fundoplication: 
a follow-up study.”  Rantanen TK, Salo JA, Salminen JT, Kellokumpu IH.  
Arch Surg. 1999;134(3):240 –244. 
39.  “Nissen fundoplication for gastroesophageal reflux disease. Evaluation 
of primary repair in 100 consecutive patients.” DeMeester TR, Bonavina 
L, Albertucci M.  Ann Surg. 1986;204(1):9 –20. 
40.  “Selective use of esophageal manometry and 24-Hour pH monitoring 
before laparoscopic fundoplication.” Frantzides CT, Carlson MA, Madan 
AK, et al. J Am Coll Surg. 2003;197(3):358 –363; discussion 363–364. 
41.  “Laparoscopic floppy Nissen fundoplication.” Richardson WS, Hunter 
JG. Am J Surg. 1999;177(2):155–157. 
42.  “Spectrum of gastrointestinal symptoms after laparoscopic 
fundoplication.”  Swanstrom L, Wayne R.  Am J Surg. 1994;167(5): 538–
541. 
43. “Laparoscopic Nissen fundopliaction: preliminary report.” Dellemagne 
B, Weerts JM, Jehas C, Markiewicz S, Lombard R. Surg Laparosc Endosc. 
1991;1:138 –143. 
44.  “Laparoscopic Nissen fundoplication: five-year results and beyond.” 
Lafullarde T, Watson DI, Jamieson GG, Myers JC, Game PA, Devitt PG. 
Arch Surg. 2001;136:180 –184. 
45.  “Five- to eight year outcome of the first laparoscopic Nissen 
fundoplication.” Bammer T, Hinder RA, Klaus A, Klingler PJ.  J 
Gastrointest Surg. 2001;5:42– 46. 
46.  “Laparoscopic antireflux sugery: five-year results and beyond in 1340 
patients.” Pessaux P, Arnaud JP, Delattre JF, Meyer C, Baulieux J, Mosnier 
H. Arch Surg. 2005;140:946 –951. 
47.  “Outcomes of atypical symptoms attributed to gastroesophageal reflux 
treated by laparoscopic  fundoplication.” So JBY, Zeitels SM, Rattner 
DW.  Surgery. 1998;24:28 –32.  
48.  “Response of atypical symptoms of gastro-oesophageal reflux to 
antireflux surgery.” Farrell TW, Richardson WS, Trus TL, Smith CD, 
Hunter JG. Br J Surg. 2001;88:1649 –1652. 
49.  “Oesophageal manometry and pH recording does not predict the bad 
results of Nissen fundoplication.” Mughal MM, Bancewicz J, Marples M.  
Br J Surg. 1990;77:43– 45. 
50.  “Laparoscopic Nissen fundoplication offers high patient satisfaction 
with relief of extraesophageal symptoms of gastroesophageal reflux 
disease.” Rakita S, Villadolid D, Thomas A, et al. Am Surg. 2006;72:207–
212. 
51.  “Laparoscopic Nissen fundoplication in a community hospital: patient 
satisfaction survey.” Tucker L, Blatt C, Richardson NL, Richardson DT, 
Cassat JD,Riechers TB. South Med J. 2005;98: 441–443. 
52.  “Long-term gasto-intestinal symptoms after laparoscopic Nissen 
fundoplication.” Beldi G, Glattli A. Surg Laparosc Endosc Percutan. 
2002;12:316 –319. 
53. “The treatment of gastroesophageal reflux disease with laparoscopic 
Nissen fundoplication: prospective evaluation of 100 patients with 
“typical”symptoms.” Peters JH, DeMeester TR, Crookes P, et al.  Ann 
Surg. 1998;228:40 –50 
54.  “Laparoscopic Nissen fundoplication improves quality of life in 
patients with atypical symptoms of gastroesophageal reflux.” Duffy JP, 
Maggard M, Hiyama DT, et al. Am Surg. 2003;69:833–838. 
55.  “Results of laparoscopic fundoplication where atypical symptoms 
coexist with oesophageal reflux.” Chen RYM, Thomas RJS. Aust N Z J 
Surg. 2000;70:840–842. 
56.  “Laparoscopic Nissen fundoplication for gastroesophageal reflux 
disease.” Ritter DW, Vanderpool D, Westmoreland M. Am J Surg. 
1997;174:715–717. Vol. 11, No. 1 
 
